Volume 25, Number 10—October 2019
Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus
|Name||Recombinant spike protein–based indirect immunofluorescence test, reciprocal endpoint titers*
*All serum samples were tested in a dilution range of 1:20 to 1:5,120. CoV, coronavirus; HCoV, human CoV; MERS, Middle East respiratory syndrome; NR, nonreactive at the cutoff serum dilution of 1:20; SARS, severe acute respiratory syndrome; WHO, World Health Organization.
1Study participants who contributed data are listed at the end of this article.